Press Releases Sol-Gel Technologies Ltd.

Equities

SLGL

IL0011417206

Market Closed - Nasdaq Other stock markets 04:30:01 2024-05-01 pm EDT			5-day change	1st Jan Change
0.782 ^USD	+9.75%		-15.00%	-29.23%

Mar. 13	Sol-Gel Technologies Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 29	Sol-Gel Technologies Ltd. Elects Yuval Yanai as External Director	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream	Apr. 01	AQ
Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments	Mar. 13	AQ
Sol-Gel Technologies Screens First Patient for SGT-610 Phase 3 Study	Nov. 30	AQ
Sol-Gel Technologies Ltd to Host Virtual KOL Event on Gorlin Syndrome and the Upcoming Phase 3 Trial for SGT-610	Nov. 28	AQ
Sol Gel Technologies : INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K - Form 6-K	Nov. 20	PU
Sol-Gel Technologies Reports Third Quarter 2023 Financial Results and Provides Corporate Update	Nov. 09	AQ
Sol-Gel Technologies to Participate in the H.C. Wainwright 25th Annual Global Investment Conference	23-08-30	AQ
Sol-Gel Technologies Reports Second Quarter 2023 Financial Results and Provides Corporate Update	23-08-10	AQ
Sol Gel Technologies : NOTICE OF ANNUAL MEETING OF SHAREHOLDERS - Form 6-K	23-06-21	PU
Sol Gel Technologies : NOTICE OF ANNUAL MEETING OF SHAREHOLDERS - Form 6-K	23-06-14	PU
Sol-Gel and Searchlight Pharma Announce Licensing Agreements to Commercialize TWYNEO® and EPSOLAY® in Canada	23-06-06	AQ
Sol-Gel Technologies Reports First Quarter 2023 Financial Results and Provides Corporate Update	23-05-12	AQ
Sol-Gel Technologies to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference	23-03-20	AQ
Sol-Gel Reports Full-Year 2022 Financial Results and Corporate Developments	23-03-10	AQ
Sol Gel Technologies : NOTICE OF SPECIAL MEETING OF SHAREHOLDERS - Form 6-K	23-03-01	PU
Sol Gel Technologies : Gel Corporate Presentation	23-02-02	PU
Sol-Gel Announces Aggregate $22.8 Million Concurrent Registered Direct and Private Placement Offerings	23-01-30	AQ
Sol Gel Technologies : Gel Corporate Presentation	23-01-30	PU
Sol Gel Technologies : Patidegib Acquisition Call	23-01-27	PU
Sol-Gel Announces Aggregate $22.8 Million Concurrent Registered Direct and Private Placement Offerings	23-01-27	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Sol-Gel Technologies Ltd.

Equities

SLGL

IL0011417206

Press Releases

Filters